325 related articles for article (PubMed ID: 17141809)
1. Tissue distribution evaluation of stealth pH-sensitive liposomal cisplatin versus free cisplatin in Ehrlich tumor-bearing mice.
Júnior AD; Mota LG; Nunan EA; Wainstein AJ; Wainstein AP; Leal AS; Cardoso VN; De Oliveira MC
Life Sci; 2007 Jan; 80(7):659-64. PubMed ID: 17141809
[TBL] [Abstract][Full Text] [Related]
2. Biodistribution and antitumoral effect of long-circulating and pH-sensitive liposomal cisplatin administered in Ehrlich tumor-bearing mice.
Araújo JG; Mota Ld; Leite EA; Maroni Lde C; Wainstein AJ; Coelho LG; Savassi-Rocha PR; Pereira MT; de Carvalho AT; Cardoso VN; De Oliveira MC
Exp Biol Med (Maywood); 2011 Jul; 236(7):808-15. PubMed ID: 21685237
[TBL] [Abstract][Full Text] [Related]
3. Acute toxicity of long-circulating and pH-sensitive liposomes containing cisplatin in mice after intraperitoneal administration.
Leite EA; Giuberti Cdos S; Wainstein AJ; Wainstein AP; Coelho LG; Lana AM; Savassi-Rocha PR; De Oliveira MC
Life Sci; 2009 May; 84(19-20):641-9. PubMed ID: 19302806
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effectiveness and toxicity of cisplatin-loaded long-circulating and pH-sensitive liposomes against Ehrlich ascitic tumor.
de Carvalho Maroni L; de Oliveira Silveira AC; Leite EA; Melo MM; de Carvalho Ribeiro AF; Cassali GD; de Souza CM; Souza-Fagundes EM; Caldas IR; Araújo MS; Martins-Filho OA; de Oliveira MC; Teixeira-Carvalho A
Exp Biol Med (Maywood); 2012 Aug; 237(8):973-84. PubMed ID: 22903135
[TBL] [Abstract][Full Text] [Related]
5. Study of the pilot production process of long-circulating and pH-sensitive liposomes containing cisplatin.
dos Santos Giuberti C; de Oliveira Reis EC; Ribeiro Rocha TG; Leite EA; Lacerda RG; Ramaldes GA; de Oliveira MC
J Liposome Res; 2011 Mar; 21(1):60-9. PubMed ID: 20429813
[TBL] [Abstract][Full Text] [Related]
6. Encapsulation of cisplatin in long-circulating and pH-sensitive liposomes improves its antitumor effect and reduces acute toxicity.
Leite EA; Souza CM; Carvalho-Júnior AD; Coelho LG; Lana AM; Cassali GD; Oliveira MC
Int J Nanomedicine; 2012; 7():5259-69. PubMed ID: 23091378
[TBL] [Abstract][Full Text] [Related]
7. Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma.
Zamboni WC; Gervais AC; Egorin MJ; Schellens JH; Zuhowski EG; Pluim D; Joseph E; Hamburger DR; Working PK; Colbern G; Tonda ME; Potter DM; Eiseman JL
Cancer Chemother Pharmacol; 2004 Apr; 53(4):329-36. PubMed ID: 14673619
[TBL] [Abstract][Full Text] [Related]
8. Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice.
Nishiyama N; Okazaki S; Cabral H; Miyamoto M; Kato Y; Sugiyama Y; Nishio K; Matsumura Y; Kataoka K
Cancer Res; 2003 Dec; 63(24):8977-83. PubMed ID: 14695216
[TBL] [Abstract][Full Text] [Related]
9. Intestinal toxicity evaluation of long-circulating and pH-sensitive liposomes loaded with cisplatin.
Araújo RS; Silveira ALM; de Sales E Souza ÉL; Freire RH; de Souza CM; Reis DC; Costa BRC; Sugimoto MA; Silveira JN; Dos Santos Martins F; Cassali GD; Leite JIA; Sousa LP; Ferreira AVM; Oliveira MC; Cardoso VN
Eur J Pharm Sci; 2017 Aug; 106():142-151. PubMed ID: 28546107
[TBL] [Abstract][Full Text] [Related]
10. Acute toxicity study of cisplatin loaded long-circulating and pH-sensitive liposomes administered in mice.
Leite EA; Lana AM; Junior AD; Coelho LG; De Oliveira MC
J Biomed Nanotechnol; 2012 Apr; 8(2):229-39. PubMed ID: 22515074
[TBL] [Abstract][Full Text] [Related]
11. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice.
Kim JH; Kim YS; Park K; Lee S; Nam HY; Min KH; Jo HG; Park JH; Choi K; Jeong SY; Park RW; Kim IS; Kim K; Kwon IC
J Control Release; 2008 Apr; 127(1):41-9. PubMed ID: 18234388
[TBL] [Abstract][Full Text] [Related]
12. Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice.
Newman MS; Colbern GT; Working PK; Engbers C; Amantea MA
Cancer Chemother Pharmacol; 1999; 43(1):1-7. PubMed ID: 9923534
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics, biodistribution and in vivo efficacy of cisplatin loaded poly(L-glutamic acid)-g-methoxy poly(ethylene glycol) complex nanoparticles for tumor therapy.
Yu H; Tang Z; Zhang D; Song W; Zhang Y; Yang Y; Ahmad Z; Chen X
J Control Release; 2015 May; 205():89-97. PubMed ID: 25529533
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and tissue distribution of iv injection of polyphase liposome-encapsulated cisplatin (KM-1) in rats.
Wang S; Mi JB; Li YZ; Chang WB; Ci YX; Zhao MZ; Zhao YK; Zhu LY; Xu G
Acta Pharmacol Sin; 2003 Jun; 24(6):589-92. PubMed ID: 12791187
[TBL] [Abstract][Full Text] [Related]
15. Treatment of murine SCC VII tumors with localized hyperthermia and temperature-sensitive liposomes containing cisplatin.
Nishimura Y; Ono K; Hiraoka M; Masunaga S; Jo S; Shibamoto Y; Sasai K; Abe M; Iga K; Ogawa Y
Radiat Res; 1990 May; 122(2):161-7. PubMed ID: 2336462
[TBL] [Abstract][Full Text] [Related]
16. Biodistribution analysis of cisplatin in liposomal form in animals with cisplatin-resistant and cisplatin-sensitive carcinoma.
Nosko MM; Pivnyuk VM; Solyanik GI; Kulik GI; Todor IN; Momot VY; Melnikov OR; Ponomareva OV; Chekhun VF
Exp Oncol; 2010 Mar; 32(1):40-3. PubMed ID: 20355294
[TBL] [Abstract][Full Text] [Related]
17. Inter- and intratumoral disposition of platinum in solid tumors after administration of cisplatin.
Zamboni WC; Gervais AC; Egorin MJ; Schellens JH; Hamburger DR; Delauter BJ; Grim A; Zuhowski EG; Joseph E; Pluim D; Potter DM; Eiseman JL
Clin Cancer Res; 2002 Sep; 8(9):2992-9. PubMed ID: 12231546
[TBL] [Abstract][Full Text] [Related]
18. Novel and simple loading procedure of cisplatin into liposomes and targeting tumor endothelial cells.
Hirai M; Minematsu H; Hiramatsu Y; Kitagawa H; Otani T; Iwashita S; Kudoh T; Chen L; Li Y; Okada M; Salomon DS; Igarashi K; Chikuma M; Seno M
Int J Pharm; 2010 May; 391(1-2):274-83. PubMed ID: 20211714
[TBL] [Abstract][Full Text] [Related]
19. Nanospheres-incorporated implantable hydrogel as a trans-tissue drug delivery system.
Ding D; Zhu Z; Li R; Li X; Wu W; Jiang X; Liu B
ACS Nano; 2011 Apr; 5(4):2520-34. PubMed ID: 21428432
[TBL] [Abstract][Full Text] [Related]
20. Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy?
Cui J; Li C; Guo W; Li Y; Wang C; Zhang L; Zhang L; Hao Y; Wang Y
J Control Release; 2007 Apr; 118(2):204-15. PubMed ID: 17239468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
